| - GRCh37:
- Chr3:138664638
- GRCh38:
- Chr3:138945796
| FOXL2 | P310fs | Blepharophimosis, ptosis, and epicanthus inversus syndrome | Likely pathogenic (Apr 4, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr3:138665355
- GRCh38:
- Chr3:138946513
| FOXL2 | S70R | Blepharophimosis, ptosis, and epicanthus inversus syndrome | Uncertain significance (Nov 18, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:138665351
- GRCh38:
- Chr3:138946509
| FOXL2 | E72* | Blepharophimosis, ptosis, and epicanthus inversus syndrome | Likely pathogenic (Sep 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:138664796-138664797
- GRCh38:
- Chr3:138945954-138945955
| FOXL2 | P257fs | Blepharophimosis, ptosis, and epicanthus inversus syndrome | Pathogenic (Sep 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:138665225
- GRCh38:
- Chr3:138946383
| FOXL2 | K114* | Blepharophimosis, ptosis, and epicanthus inversus syndrome | Pathogenic (Feb 2, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:138664787-138664790
- GRCh38:
- Chr3:138945945-138945948
| FOXL2 | T259fs | Blepharophimosis, ptosis, and epicanthus inversus syndrome, not provided | Pathogenic/Likely pathogenic (Aug 16, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:138664891-138664893
- GRCh38:
- Chr3:138946049-138946051
| FOXL2 | A234del | not provided, Blepharophimosis, ptosis, and epicanthus inversus syndrome, Premature ovarian failure 3
| Conflicting interpretations of pathogenicity (Aug 23, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr3:138665299
- GRCh38:
- Chr3:138946457
| FOXL2 | P89Q | Blepharophimosis, ptosis, and epicanthus inversus syndrome | Likely pathogenic (Mar 28, 2019) | no assertion criteria provided |
| - GRCh37:
- Chr3:138664610-138664617
- GRCh38:
- Chr3:138945768-138945775
| FOXL2 | P317fs | Blepharophimosis, ptosis, and epicanthus inversus syndrome | Pathogenic (May 28, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr3:138664620-138664621
- GRCh38:
- Chr3:138945778-138945779
| FOXL2 | A316fs | Blepharophimosis, ptosis, and epicanthus inversus syndrome | Pathogenic (Jan 1, 2016) | no assertion criteria provided |
| - GRCh37:
- Chr3:138664653-138664654
- GRCh38:
- Chr3:138945811-138945812
| FOXL2 | P305fs | Blepharophimosis, ptosis, and epicanthus inversus syndrome | Pathogenic (Jan 1, 2016) | no assertion criteria provided |
| - GRCh37:
- Chr3:138664568-138664630
- GRCh38:
- Chr3:138945726-138945788
| FOXL2 | H312fs | Blepharophimosis, ptosis, and epicanthus inversus syndrome | Pathogenic (Jan 1, 2015) | no assertion criteria provided |
| - GRCh37:
- Chr3:138664723-138664724
- GRCh38:
- Chr3:138945881-138945882
| FOXL2 | P281fs | Blepharophimosis, ptosis, and epicanthus inversus syndrome | Pathogenic (Jan 1, 2011) | no assertion criteria provided |
| - GRCh37:
- Chr3:138664747
- GRCh38:
- Chr3:138945905
| FOXL2 | S273* | Blepharophimosis, ptosis, and epicanthus inversus syndrome | Pathogenic (Jan 1, 2015) | no assertion criteria provided |
| - GRCh37:
- Chr3:138664781
- GRCh38:
- Chr3:138945939
| FOXL2 | Q262* | Blepharophimosis, ptosis, and epicanthus inversus syndrome | Pathogenic (Jan 1, 2014) | no assertion criteria provided |
| - GRCh37:
- Chr3:138664792
- GRCh38:
- Chr3:138945950
| FOXL2 | Y258fs | Blepharophimosis, ptosis, and epicanthus inversus syndrome | Pathogenic (Jan 1, 2015) | no assertion criteria provided |
| - GRCh37:
- Chr3:138664847
- GRCh38:
- Chr3:138946005
| FOXL2 | G240C | Blepharophimosis, ptosis, and epicanthus inversus syndrome | Uncertain significance (Jan 1, 2014) | no assertion criteria provided |
| - GRCh37:
- Chr3:138664795-138664796
- GRCh38:
- Chr3:138945953-138945954
| FOXL2 | P257fs | Blepharophimosis, ptosis, and epicanthus inversus syndrome | Pathogenic (Jan 1, 2018) | no assertion criteria provided |
| - GRCh37:
- Chr3:138664884-138664896
- GRCh38:
- Chr3:138946042-138946054
| FOXL2 | A224fs | Blepharophimosis, ptosis, and epicanthus inversus syndrome | Pathogenic (Jan 1, 2010) | no assertion criteria provided |
| - GRCh37:
- Chr3:138665013-138665014
- GRCh38:
- Chr3:138946171-138946172
| FOXL2 | D184fs | Blepharophimosis, ptosis, and epicanthus inversus syndrome | Pathogenic (Jan 1, 2010) | no assertion criteria provided |
| - GRCh37:
- Chr3:138665015-138665016
- GRCh38:
- Chr3:138946173-138946174
| FOXL2 | D184fs | Blepharophimosis, ptosis, and epicanthus inversus syndrome | Pathogenic (Jan 1, 2018) | no assertion criteria provided |
| - GRCh37:
- Chr3:138665040
- GRCh38:
- Chr3:138946198
| FOXL2 | C176fs | Blepharophimosis, ptosis, and epicanthus inversus syndrome | Pathogenic (Jan 1, 2017) | no assertion criteria provided |
| - GRCh37:
- Chr3:138665095-138665096
- GRCh38:
- Chr3:138946253-138946254
| FOXL2 | P157fs | Blepharophimosis, ptosis, and epicanthus inversus syndrome | Pathogenic (Jan 1, 2010) | no assertion criteria provided |
| - GRCh37:
- Chr3:138665166
- GRCh38:
- Chr3:138946324
| FOXL2 | C134fs | Blepharophimosis, ptosis, and epicanthus inversus syndrome | Pathogenic (Jan 1, 2012) | no assertion criteria provided |
| - GRCh37:
- Chr3:138665178
- GRCh38:
- Chr3:138946336
| FOXL2 | L130fs | Blepharophimosis, ptosis, and epicanthus inversus syndrome | Pathogenic (Jan 1, 2011) | no assertion criteria provided |
| - GRCh37:
- Chr3:138665181
- GRCh38:
- Chr3:138946339
| FOXL2 | W128* | Blepharophimosis, ptosis, and epicanthus inversus syndrome | Pathogenic (Jan 1, 2014) | no assertion criteria provided |
| - GRCh37:
- Chr3:138665181
- GRCh38:
- Chr3:138946339
| FOXL2 | | Blepharophimosis, ptosis, and epicanthus inversus syndrome | Pathogenic (Jan 1, 2016) | no assertion criteria provided |
| - GRCh37:
- Chr3:138665184-138665185
- GRCh38:
- Chr3:138946342-138946343
| FOXL2 | Y127* | Blepharophimosis, ptosis, and epicanthus inversus syndrome | Pathogenic (Jan 1, 2018) | no assertion criteria provided |
| - GRCh37:
- Chr3:138665512-138665513
- GRCh38:
- Chr3:138946670-138946671
| FOXL2 | P18fs | Blepharophimosis, ptosis, and epicanthus inversus syndrome | Pathogenic (Jan 1, 2010) | no assertion criteria provided |
| - GRCh37:
- Chr3:138665547
- GRCh38:
- Chr3:138946705
| FOXL2 | E7fs | Blepharophimosis, ptosis, and epicanthus inversus syndrome | Pathogenic (Jan 1, 2014) | no assertion criteria provided |
| - GRCh37:
- Chr3:138664462
- GRCh38:
- Chr3:138945620
| FOXL2 | G368fs | Blepharophimosis, ptosis, and epicanthus inversus syndrome | Pathogenic (Jan 1, 2014) | no assertion criteria provided |
| - GRCh37:
- Chr3:138664566-138664567
- GRCh38:
- Chr3:138945724-138945725
| FOXL2 | A334fs | Blepharophimosis, ptosis, and epicanthus inversus syndrome | Pathogenic (Jan 1, 2015) | no assertion criteria provided |
| - GRCh37:
- Chr3:138665225-138665227
- GRCh38:
- Chr3:138946383-138946385
| FOXL2 | I113del | Blepharophimosis, ptosis, and epicanthus inversus syndrome | Likely pathogenic (Jan 1, 2017) | no assertion criteria provided |
| - GRCh37:
- Chr3:138665267
- GRCh38:
- Chr3:138946425
| FOXL2 | N100D | Blepharophimosis, ptosis, and epicanthus inversus syndrome | Likely pathogenic (Jan 1, 2018) | no assertion criteria provided |
| - GRCh37:
- Chr3:138665299
- GRCh38:
- Chr3:138946457
| FOXL2 | P89R | Blepharophimosis, ptosis, and epicanthus inversus syndrome | Likely pathogenic (Jan 1, 2019) | no assertion criteria provided |
| - GRCh37:
- Chr3:138665303
- GRCh38:
- Chr3:138946461
| FOXL2 | F88I | Blepharophimosis, ptosis, and epicanthus inversus syndrome | Likely pathogenic (Jan 1, 2018) | no assertion criteria provided |
| - GRCh37:
- Chr3:138665335
- GRCh38:
- Chr3:138946493
| FOXL2 | L77P | Blepharophimosis, ptosis, and epicanthus inversus syndrome | Likely pathogenic (Jan 1, 2010) | criteria provided, single submitter |
| - GRCh37:
- Chr3:138665372
- GRCh38:
- Chr3:138946530
| FOXL2 | M65V | Blepharophimosis, ptosis, and epicanthus inversus syndrome | Likely pathogenic (Jan 1, 2011) | criteria provided, single submitter |
| - GRCh37:
- Chr3:138665377
- GRCh38:
- Chr3:138946535
| FOXL2 | I63N | Blepharophimosis, ptosis, and epicanthus inversus syndrome | Likely pathogenic (Jan 1, 2017) | no assertion criteria provided |
| - GRCh37:
- Chr3:138665390
- GRCh38:
- Chr3:138946548
| FOXL2 | Y59D | Blepharophimosis, ptosis, and epicanthus inversus syndrome | Likely pathogenic (Jan 1, 2017) | no assertion criteria provided |
| - GRCh37:
- Chr3:138665379-138665391
- GRCh38:
- Chr3:138946537-138946549
| FOXL2 | Y59fs | Blepharophimosis, ptosis, and epicanthus inversus syndrome | Pathogenic (Jan 1, 2013) | no assertion criteria provided |
| - GRCh37:
- Chr3:138665392
- GRCh38:
- Chr3:138946550
| FOXL2 | S58W | Blepharophimosis, ptosis, and epicanthus inversus syndrome | Likely pathogenic (Jan 1, 2018) | no assertion criteria provided |
| - GRCh37:
- Chr3:138665396
- GRCh38:
- Chr3:138946554
| FOXL2 | Y57N | Blepharophimosis, ptosis, and epicanthus inversus syndrome | Likely pathogenic (Jan 1, 2014) | no assertion criteria provided |
| - GRCh37:
- Chr3:138665405
- GRCh38:
- Chr3:138946563
| FOXL2 | K54E | Blepharophimosis, ptosis, and epicanthus inversus syndrome | Pathogenic (Jan 1, 2017) | no assertion criteria provided |
| - GRCh37:
- Chr3:138665510
- GRCh38:
- Chr3:138946668
| FOXL2 | E19* | Blepharophimosis, ptosis, and epicanthus inversus syndrome | Pathogenic (Jan 1, 2013) | no assertion criteria provided |
| - GRCh37:
- Chr3:138664864-138664865
- GRCh38:
- Chr3:138946022-138946023
| FOXL2 | | Blepharophimosis, ptosis, and epicanthus inversus syndrome | Pathogenic (Jul 29, 2014) | criteria provided, single submitter |
| - GRCh37:
- Chr3:138925589-139157532
| COPB2, MRPS22 | | Blepharophimosis, ptosis, and epicanthus inversus syndrome | Pathogenic (Aug 22, 2017) | no assertion criteria provided |
| - GRCh37:
- Chr3:138665075
- GRCh38:
- Chr3:138946233
| FOXL2 | K164* | Blepharophimosis, ptosis, and epicanthus inversus syndrome | Pathogenic | no assertion criteria provided |
| - GRCh37:
- Chr3:138665462-138665463
- GRCh38:
- Chr3:138946620-138946621
| FOXL2 | G35fs | Blepharophimosis, ptosis, and epicanthus inversus syndrome | Pathogenic (Nov 7, 2016) | no assertion criteria provided |
| - GRCh37:
- Chr3:138664554
- GRCh38:
- Chr3:138945712
| FOXL2 | T338fs | Blepharophimosis, ptosis, and epicanthus inversus syndrome | Pathogenic (Nov 3, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr3:138664583
- GRCh38:
- Chr3:138945741
| FOXL2 | A328fs | Blepharophimosis, ptosis, and epicanthus inversus syndrome | Pathogenic (Nov 3, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr3:138664603-138664604
- GRCh38:
- Chr3:138945761-138945762
| FOXL2 | Q321fs | Blepharophimosis, ptosis, and epicanthus inversus syndrome | Pathogenic (Nov 3, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr3:138664638-138664639
- GRCh38:
- Chr3:138945796-138945797
| FOXL2 | H312fs | Blepharophimosis, ptosis, and epicanthus inversus syndrome | Pathogenic (Nov 3, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr3:138664672-138664673
- GRCh38:
- Chr3:138945830-138945831
| FOXL2 | H298fs | Blepharophimosis, ptosis, and epicanthus inversus syndrome | Pathogenic (Nov 3, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr3:138664708-138664709
- GRCh38:
- Chr3:138945866-138945867
| FOXL2 | P286fs | Blepharophimosis, ptosis, and epicanthus inversus syndrome | Pathogenic (Nov 3, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr3:138664694-138664725
- GRCh38:
- Chr3:138945852-138945883
| FOXL2 | A283fs | Blepharophimosis, ptosis, and epicanthus inversus syndrome | Pathogenic (Nov 3, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr3:138664737-138664738
- GRCh38:
- Chr3:138945895-138945896
| FOXL2 | L277fs | Blepharophimosis, ptosis, and epicanthus inversus syndrome | Pathogenic (Nov 3, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr3:138664761
- GRCh38:
- Chr3:138945919
| FOXL2 | G269fs | Blepharophimosis, ptosis, and epicanthus inversus syndrome | Pathogenic (Nov 3, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr3:138664766
- GRCh38:
- Chr3:138945924
| FOXL2 | P267T | Blepharophimosis, ptosis, and epicanthus inversus syndrome | Likely benign (Nov 3, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr3:138664787-138664788
- GRCh38:
- Chr3:138945945-138945946
| FOXL2 | R260fs | Blepharophimosis, ptosis, and epicanthus inversus syndrome | Pathogenic (Nov 3, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr3:138664816-138664817
- GRCh38:
- Chr3:138945974-138945975
| FOXL2 | G250fs | Blepharophimosis, ptosis, and epicanthus inversus syndrome | Pathogenic (Nov 3, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr3:138664860-138664887
- GRCh38:
- Chr3:138946018-138946045
| FOXL2 | A227fs | Blepharophimosis, ptosis, and epicanthus inversus syndrome | Pathogenic (Nov 3, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr3:138664861-138664862
- GRCh38:
- Chr3:138946019-138946020
| FOXL2 | | Blepharophimosis, ptosis, and epicanthus inversus syndrome | Pathogenic (Nov 3, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr3:138664870-138664891
- GRCh38:
- Chr3:138946028-138946049
| FOXL2 | A225fs | Blepharophimosis, ptosis, and epicanthus inversus syndrome | Pathogenic (Nov 3, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr3:138664872-138664873
- GRCh38:
- Chr3:138946030-138946031
| FOXL2 | | not provided, Blepharophimosis, ptosis, and epicanthus inversus syndrome | Pathogenic (Apr 28, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:138664876-138664903
- GRCh38:
- Chr3:138946034-138946061
| FOXL2 | A221fs | Blepharophimosis, ptosis, and epicanthus inversus syndrome | Pathogenic (Nov 3, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr3:138664909
- GRCh38:
- Chr3:138946067
| FOXL2 | Q219L | Blepharophimosis, ptosis, and epicanthus inversus syndrome | Uncertain significance (Nov 3, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr3:138664918
- GRCh38:
- Chr3:138946076
| FOXL2 | A216V | Blepharophimosis, ptosis, and epicanthus inversus syndrome | Uncertain significance (Nov 3, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr3:138664921
- GRCh38:
- Chr3:138946079
| FOXL2 | Y215C | Blepharophimosis, ptosis, and epicanthus inversus syndrome, not provided | Pathogenic/Likely pathogenic (Feb 2, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:138664933
- GRCh38:
- Chr3:138946091
| FOXL2 | S211* | Blepharophimosis, ptosis, and epicanthus inversus syndrome | Pathogenic (Nov 3, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr3:138664913-138664914
- GRCh38:
- Chr3:138946071-138946072
| FOXL2 | C218fs | Blepharophimosis, ptosis, and epicanthus inversus syndrome | Pathogenic (Nov 3, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr3:138664947
- GRCh38:
- Chr3:138946105
| FOXL2 | P207fs | Blepharophimosis, ptosis, and epicanthus inversus syndrome | Pathogenic (Nov 3, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr3:138664953
- GRCh38:
- Chr3:138946111
| FOXL2 | W204* | Blepharophimosis, ptosis, and epicanthus inversus syndrome | Pathogenic (Nov 3, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr3:138664983
- GRCh38:
- Chr3:138946141
| FOXL2 | Y194* | Blepharophimosis, ptosis, and epicanthus inversus syndrome | Pathogenic (Nov 3, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr3:138664987
- GRCh38:
- Chr3:138946145
| FOXL2 | K193R | Blepharophimosis, ptosis, and epicanthus inversus syndrome | Uncertain significance (May 22, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:138664988-138664989
- GRCh38:
- Chr3:138946146-138946147
| FOXL2 | K193fs | not provided, Blepharophimosis, ptosis, and epicanthus inversus syndrome | Pathogenic (Jun 17, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:138665176
- GRCh38:
- Chr3:138946334
| FOXL2 | L130P | Blepharophimosis, ptosis, and epicanthus inversus syndrome | Uncertain significance (Nov 3, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr3:138665176
- GRCh38:
- Chr3:138946334
| FOXL2 | L130Q | Blepharophimosis, ptosis, and epicanthus inversus syndrome | Uncertain significance (Nov 3, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr3:138665088-138665089
- GRCh38:
- Chr3:138946246-138946247
| FOXL2 | H159fs | Blepharophimosis, ptosis, and epicanthus inversus syndrome | Pathogenic (Nov 3, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr3:138665225
- GRCh38:
- Chr3:138946383
| FOXL2 | K114E | Blepharophimosis, ptosis, and epicanthus inversus syndrome | Likely pathogenic (Nov 3, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr3:138665227
- GRCh38:
- Chr3:138946385
| FOXL2 | I113fs | Blepharophimosis, ptosis, and epicanthus inversus syndrome | Pathogenic (Nov 3, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr3:138665246
- GRCh38:
- Chr3:138946404
| FOXL2 | S107G | Blepharophimosis, ptosis, and epicanthus inversus syndrome | Likely pathogenic (Nov 3, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr3:138665249
- GRCh38:
- Chr3:138946407
| FOXL2 | L106F | Blepharophimosis, ptosis, and epicanthus inversus syndrome | Likely pathogenic (Nov 3, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr3:138665246-138665251
- GRCh38:
- Chr3:138946404-138946409
| FOXL2 | | Blepharophimosis, ptosis, and epicanthus inversus syndrome | Uncertain significance (Nov 3, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr3:138665250-138665252
- GRCh38:
- Chr3:138946408-138946410
| FOXL2 | N105del | Blepharophimosis, ptosis, and epicanthus inversus syndrome | Uncertain significance (Nov 3, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr3:138665254
- GRCh38:
- Chr3:138946412
| FOXL2 | H104R | Blepharophimosis, ptosis, and epicanthus inversus syndrome | Likely pathogenic (Nov 3, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr3:138665257
- GRCh38:
- Chr3:138946415
| FOXL2 | R103L | Blepharophimosis, ptosis, and epicanthus inversus syndrome | Uncertain significance (Nov 3, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr3:138665257
- GRCh38:
- Chr3:138946415
| FOXL2 | R103H | Blepharophimosis, ptosis, and epicanthus inversus syndrome | Uncertain significance (Nov 3, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr3:138665262
- GRCh38:
- Chr3:138946420
| FOXL2 | S101R | Blepharophimosis, ptosis, and epicanthus inversus syndrome | Likely pathogenic (Nov 3, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr3:138665272
- GRCh38:
- Chr3:138946430
| FOXL2 | W98* | Blepharophimosis, ptosis, and epicanthus inversus syndrome | Pathogenic (Nov 3, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr3:138665273
- GRCh38:
- Chr3:138946431
| FOXL2 | W98R | Blepharophimosis, ptosis, and epicanthus inversus syndrome | Likely pathogenic (Nov 3, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr3:138665309
- GRCh38:
- Chr3:138946467
| FOXL2 | A86P | Blepharophimosis, ptosis, and epicanthus inversus syndrome | Uncertain significance (Nov 3, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr3:138665332
- GRCh38:
- Chr3:138946490
| FOXL2 | S78Y | Inborn genetic diseases, Blepharophimosis, ptosis, and epicanthus inversus syndrome | Uncertain significance (Apr 8, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:138665357
- GRCh38:
- Chr3:138946515
| FOXL2 | S70G | Blepharophimosis, ptosis, and epicanthus inversus syndrome | Uncertain significance (Nov 3, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr3:138665360
- GRCh38:
- Chr3:138946518
| FOXL2 | E69* | Blepharophimosis, ptosis, and epicanthus inversus syndrome | Pathogenic (Nov 3, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr3:138665370
- GRCh38:
- Chr3:138946528
| FOXL2 | M65I | Blepharophimosis, ptosis, and epicanthus inversus syndrome | Likely pathogenic (Nov 3, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr3:138665378
- GRCh38:
- Chr3:138946536
| FOXL2 | I63L | Blepharophimosis, ptosis, and epicanthus inversus syndrome | Likely pathogenic (Nov 3, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr3:138665366-138665367
- GRCh38:
- Chr3:138946524-138946525
| FOXL2 | | Blepharophimosis, ptosis, and epicanthus inversus syndrome | Uncertain significance (Nov 3, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr3:138665392
- GRCh38:
- Chr3:138946550
| FOXL2 | S58* | Blepharophimosis, ptosis, and epicanthus inversus syndrome | Pathogenic (Nov 3, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr3:138665394
- GRCh38:
- Chr3:138946552
| FOXL2 | Y57* | Blepharophimosis, ptosis, and epicanthus inversus syndrome | Pathogenic (Nov 3, 2016) | criteria provided, single submitter |